TY - JOUR
KW - buprenorphine
KW - opioid use disorder
KW - telehealth
KW - Telemedicine
AU - A. G. Guillen
AU - M. Reddy
AU - S. Saadat
AU - B. Chakravarthy
A1 - 
AB - Background: A scoping review was conducted to examine the breadth of evidence related to telehealth innovations being utilized in the treatment of opioid use disorder (OUD) with buprenorphine and its effect on patient outcomes and health care delivery. Materials and Methods: The authors systematically searched seven databases and websites for peer-reviewed and gray literature related to telehealth solutions for buprenorphine treatment published between 2008 and March 18, 2021. Two reviewers screened titles and abstracts for articles that met the inclusion criteria, according to the scoping review study protocol. The authors included studies if they specifically examined telehealth interventions aimed at improving access to and usage of buprenorphine for OUD. Results: After screening 371 records, the authors selected 69 for full review. These studies examined the effect of telehealth on patient satisfaction, treatment retention rates, and buprenorphine accessibility and adherence. Conclusion: According to the reviewed literature, incorporation of telehealth technology with medication-assisted treatment for OUD is associated with higher patient satisfaction, comparable rates of retention, an overall reduction in health care costs, and an increase in both access to and usage of buprenorphine. This has been made possible through the expansion of telehealth technologies and a substantial push toward relaxed federal guidelines, both of which were quickly escalated in response to the COVID-19 pandemic. Future research is needed to fully quantify the effect of these factors; however, the results appear promising thus far and should urge policymakers to consider making these temporary policy changes permanent.
AD - Department of Emergency Medicine, UCI Medical Center, University of California, Irvine, Orange, California, USA.; Department of Emergency Medicine, UCI Medical Center, University of California, Irvine, Orange, California, USA.; Department of Emergency Medicine, UCI Medical Center, University of California, Irvine, Orange, California, USA.; Department of Emergency Medicine, UCI Medical Center, University of California, Irvine, Orange, California, USA.
BT - Telemedicine journal and e-health : the official journal of the American Telemedicine Association
C5 - HIT & Telehealth; Opioids & Substance Use
CY - United States
DO - 10.1089/tmj.2021.0308
JF - Telemedicine journal and e-health : the official journal of the American Telemedicine Association
LA - eng
M1 - Journal Article
N2 - Background: A scoping review was conducted to examine the breadth of evidence related to telehealth innovations being utilized in the treatment of opioid use disorder (OUD) with buprenorphine and its effect on patient outcomes and health care delivery. Materials and Methods: The authors systematically searched seven databases and websites for peer-reviewed and gray literature related to telehealth solutions for buprenorphine treatment published between 2008 and March 18, 2021. Two reviewers screened titles and abstracts for articles that met the inclusion criteria, according to the scoping review study protocol. The authors included studies if they specifically examined telehealth interventions aimed at improving access to and usage of buprenorphine for OUD. Results: After screening 371 records, the authors selected 69 for full review. These studies examined the effect of telehealth on patient satisfaction, treatment retention rates, and buprenorphine accessibility and adherence. Conclusion: According to the reviewed literature, incorporation of telehealth technology with medication-assisted treatment for OUD is associated with higher patient satisfaction, comparable rates of retention, an overall reduction in health care costs, and an increase in both access to and usage of buprenorphine. This has been made possible through the expansion of telehealth technologies and a substantial push toward relaxed federal guidelines, both of which were quickly escalated in response to the COVID-19 pandemic. Future research is needed to fully quantify the effect of these factors; however, the results appear promising thus far and should urge policymakers to consider making these temporary policy changes permanent.
PP - United States
PY - 2021
SN - 1556-3669; 1530-5627
T1 - Utilization of Telehealth Solutions for Patients with Opioid Use Disorder Using Buprenorphine: A Scoping Review
T2 - Telemedicine journal and e-health : the official journal of the American Telemedicine Association
TI - Utilization of Telehealth Solutions for Patients with Opioid Use Disorder Using Buprenorphine: A Scoping Review
U1 - HIT & Telehealth; Opioids & Substance Use
U2 - 34714172
U3 - 10.1089/tmj.2021.0308
VO - 1556-3669; 1530-5627
Y1 - 2021
Y2 - Oct 29
ER -